Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 99 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7687625

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  2. US 7683033

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted

  3. US 7666647

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted

  4. US 7662814

    4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors

    Laboratories Almirall, S.A. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  5. US 7662910

    Inhibitors for the soluble epoxide hydrolase

    The Regents of the University of California · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  6. US 7662779

    Triazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  7. US 7662999

    Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  8. US 7659283

    Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  9. US 7655752

    TNF-α converting enzyme inhibitory agents and method of using same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

  10. US 7652135

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted

  11. US 7652153

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted

  12. US 7649115

    MAO-B inhibitors useful for treating obesity

    Jenrin Discovery, LLC · Granted Jan 19, 2010 · Expires Jan 14, 2030

    granted

  13. US 7645775

    Triazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted

  14. US 7642280

    Inhibitors of acyl glucosaminyl inositol amidase and methods of use

    The Regents of the University of California · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  15. US 7642253

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  16. US 7642275

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  17. US 7642234

    Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  18. US 7638638

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  19. US 7638550

    Pyrrolic derivatives with histone deacetylase inhibitory activity

    Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU) Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III (CNIO) · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  20. US 7638543

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  21. US 7635683

    Quinoxalinyl tripeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted

  22. US 7625913

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  23. US 7622463

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  24. US 7622610

    Crystalline ACAT inhibitor

    Graceway Pharmaceuticals. LLC · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.